TITLE

Colorectal cancer prognosis: is it all mutation, mutation, mutation?

AUTHOR(S)
Hassan, A. B.; Paraskeva, C.
PUB. DATE
September 2005
SOURCE
Gut;Sep2005, Vol. 54 Issue 9, p1209
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on colorectal cancer prognosis. Mutational analysis and genetic models have identified the key pathways critical for initiation and progression of colorectal cancer. Deregulation of the Wnt signaling pathway, by either loss of function or gain of function mutations of adenomatous polyposis coli and beta-catenin, respectively, in both hereditary and sporadic colorectal adenoma, establish the principal initiation pathway. The discriminating power and clinical utility of these mutations have proven to be less impressive, even though this pathway remains to be a critical therapeutic target.
ACCESSION #
18143408

 

Related Articles

  • Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP. Lagarde, Arnaud; Rouleau, Etienne; Ferrari, Anthony; Noguchi, Tetsuro; Jinghua Qiu; Briaux, Adrien; Bourdon, Violaine; Rémy, Virginie; Gaildrat, Pascaline; Adélaïde, José; Birnbaum, Daniel; Lidereau, Rosette; Sobol, Hagay; Olschwang, Sylviane // Journal of Medical Genetics;Oct2010, Vol. 47 Issue 10, p13 

    Heterozygous APC germline alteration is responsible for familial adenomatous polyposis, a colon cancer predisposition with almost complete penetrance. Point mutations generally lead to truncated proteins or no protein at all. They mainly involve exon 3 to codon 1700 (exon 15). The work presented...

  • Genetics of the hamartomatous polyposis syndromes: a molecular review. Hui-Min Chen; Jing-Yuan Fang // International Journal of Colorectal Disease;Aug2009, Vol. 24 Issue 8, p865 

    Hamartomatous polyposis syndromes are a heterogeneous group of disorders that are inherited in an autosomal dominant fashion. These syndromes only represent a small number of the inherited gastrointestinal cancer predisposition syndromes. However, many of these syndromes carry a substantial risk...

  • Editorial: Sessile Serrated Adenomas and Their Pit Patterns: We Must First See the Forest Through the Trees. Burke, Carol A; Snover, Dale C // American Journal of Gastroenterology;Mar2012, Vol. 107 Issue 3, p470 

    Serrated lesions of the colorectum include hyperplastic polyps, which are non-neoplastic, and sessile serrated adenomas (SSAs, also known as sessile serrated polyps) and traditional serrated adenomas, which are premalignant. It is believed that up to 30% of colon cancers and many...

  • Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia. Malesci, A; Basso, G; Bianchi, P; Fini, L; Grizzi, F; Celesti, G; Di Caro, G; Delconte, G; Dattola, F; Repici, A; Roncalli, M; Montorsi, M; Laghi, L // British Journal of Cancer;3/4/2014, Vol. 110 Issue 5, p1228 

    Background:It is uncertain whether synchronous colorectal cancers (S-CRCs) preferentially develop through widespread DNA methylation and whether they have a prognosis worse than solitary CRC. As tumours with microsatellite instability (MSI) may confound the effect of S-CRC methylation on...

  • KRAS Mutational Status and its Clinical Implications in Saudi Colorectal Cancer Patients. Abulkair, Omalkhair; Alqahtani, Abdullah; Gasmelseed, Ahmed; Abdelhafiz, Nafisa; Al Olayan, Ashwaq; Saadeddin, Ahmed // Pan Arab Journal of Oncology;Mar2016, Vol. 9 Issue 1, p12 

    Background: Recent studies emphasize the role of KRAS as a prognostic marker for predicting tumor responsiveness in colorectal cancer (CRC). Earlier studies have reported the frequency of KRAS mutations in the range of 30 - 45%. Due to limited data available about the true incidence of KRAS...

  • Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Jun Yu; Wu, William K. K.; Xiangchun Li; Jun He; Xiao-Xing Li; Ng, Simon S. M.; Chang Yu; Zhibo Gao; Jie Yang; Miao Li; Qiaoxiu Wang; Qiaoyi Liang; Yi Pan; Tong, Joanna H.; To, Ka F.; Nathalie Wong; Ning Zhang; Jie Chen; Youyong Lu; Lai, Paul B. S // Gut;Apr2015, Vol. 64 Issue 4, p636 

    Background Characterisation of colorectal cancer (CRC) genomes by next-generation sequencing has led to the discovery of novel recurrently mutated genes. Nevertheless, genomic data has not yet been used for CRC prognostication. Objective To identify recurrent somatic mutations with prognostic...

  • Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Maus, M K H; Hanna, D L; Stephens, C L; Astrow, S H; Yang, D; Grimminger, P P; Loupakis, F; Hsiang, J H; Zeger, G; Wakatsuki, T; Barzi, A; Lenz, H-J // Pharmacogenomics Journal;Aug2015, Vol. 15 Issue 4, p354 

    Colorectal cancer (CRC) is a heterogeneous disease with genetic profiles and clinical outcomes dependent on the anatomic location of the primary tumor. How location has an impact on the molecular makeup of a tumor and how prognostic and predictive biomarkers differ between proximal versus distal...

  • The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study. Wu, Dong; Luo, Han-Qing; Zhou, Wei-Xun; Qian, Jia-Ming; Li, Jing-Nan // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background: Repeated qualitative fecal immunochemical test (qlFIT) is a clinical strategy widely used to detect lower gastrointestinal lesions, but its diagnostic power has not been assessed in opportunistic screening for colorectal neoplasia. Objective: This study aimed to determine the...

  • Surveillance after positive and negative colonoscopy examinations: issues, yields, and use. Schoen, Robert E. // American Journal of Gastroenterology;Jun2003, Vol. 98 Issue 6, p1237 

    As colorectal cancer screening gains acceptance by the public, the use of colonoscopy will increase. The frequency of surveillance examinations after detection of an adenoma is one of the largest contributors to the cost of colorectal cancer screening. Ten years after the publication of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics